<DOC>
	<DOCNO>NCT02005510</DOCNO>
	<brief_summary>The purpose trial determine whether mail in-home human papillomavirus ( HPV ) screen kit effective increase uptake cervical cancer screen early detection treatment cervical neoplasia underscreened woman .</brief_summary>
	<brief_title>Randomized Trial In-Home Cervical Cancer Screening Underscreened Women</brief_title>
	<detailed_description>Over half cervical cancer U.S. diagnose unscreened underscreened woman . New national guideline identify increase screen uptake number one priority reduce cervical cancer-related morbidity mortality . Innovative screening strategy eliminate need clinic-based screening could highly effective improve screen compliance maintain high-quality care . We propose large , pragmatic randomize controlled trial within Group Health ( large integrate health care delivery system Washington State ) compare effectiveness two programmatic approach increase cervical cancer screen among overdue woman . The first approach ( control arm ) usual care Group Health , consist patient- provider-level service promote adherence Pap screening , second approach ( intervention arm ) include usual care plus mailed in-home high-risk human papillomavirus ( hrHPV ) screen kit . We randomize eligible woman in-home hrHPV screen arm usual care arm . Compared usual care , hypothesize in-home hrHPV screen enhance early detection treatment cervical neoplasia improve compliance screening . The trial provide definitive evidence-based data impact in-home hrHPV screen program real-world clinical setting .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Female 30 64 year age Have primary care provider Group Health Received annual `` birthday letter '' Pap screen reminder 5 month earlier No Pap test past 3.4 year Continuously enrol Group Health least 3.4 year No hysterectomy Currently pregnant Language interpreter need On `` contact list '' research study</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>screen</keyword>
	<keyword>human papillomavirus</keyword>
	<keyword>cervical intraepithelial neoplasia</keyword>
</DOC>